Dramatic changes are sweeping through the healthcare sector. The steady decline in the return on investment of blockbuster products has meant that the key players in the sector have had to refocus efforts in other areas. Patient behaviour is also shifting dramatically with patients demanding more control over their own health data and treatment plans.
The development of increasingly intelligent digital services are now designed to prevent rather than cure illness. This fundamental change has ushered in a raft of new tech entrants to the market in addition to big pharma. At Isobar, we work with companies in this space helping them to maximise the market opportunities.